UPDATED: Sanofi/GSK report positive interim results for their COVID-19 vaccine
An experimental COVID-19 vaccine developed by Sanofi and GlaxoSmithKline showed a robust immune response in early-stage clinical trial results, enabling them to move to a late-stage study, the French drugmaker…
